Titan Pharmaceuticals/ US8883147055 /
4/30/2024 9:00:34 PM | Chg. - | Volume | Bid- | Ask- | High | Low |
---|---|---|---|---|---|---|
6.71USD | - | 9 Turnover: 60.35 |
-Bid Size: - | -Ask Size: - | 6.71 | 6.71 |
GlobeNewswire
2/8
BioCorRx Pharmaceuticals Inc. Appoints Neuroscientist Dr. Kate DeVarney to the Board of Directors
GlobeNewswire
10/16/2023
Titan Pharmaceuticals Announces Appointment of Dato' Seow Gim Shen and Brynner Chaim to the Company'...
GlobeNewswire
10/9/2023
Ashvattha Therapeutics Announces Appointment of Dr. Sakura Minami as Vice President of Translational...
GlobeNewswire
9/18/2023
Titan Pharmaceuticals Announces $9.5 Million Private Placement of Convertible Preferred Stock
GlobeNewswire
4/18/2019
Detailed Research: Economic Perspectives on TransAct Technologies, Lifeway Foods, ImmuCell, Digirad,...
GlobeNewswire
3/20/2019
Global Opioid Use Disorder (OUD) Opportunity Analysis and Forecasts 2018-2027: Experienced and New P...
GlobeNewswire
2/11/2019
Titan Pharmaceuticals Selects Life Sciences Business Intelligence CRM Innovator, TikaMobile, to Empo...
GlobeNewswire
8/16/2018
Spring Bank Pharmaceuticals, Inc. Appoints Scott Smith to its Board of Directors
GlobeNewswire
3/19/2018
Soricimed Announces the Appointment of Dr. Marc Rubin and Mr. Vaughn Embro-Pantalony to Board of Dir...